{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-028818","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.820619+00:00","generated_at":"2026-05-31T18:06:30.776508+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Evofem licenses Phexxi to Pharma 1 for Middle East; closes $500K private placement with Aditxt","bullets":["Exclusive 5-year license for Phexxi in UAE, Kuwait, Saudi Arabia, Qatar and other Middle East countries.","Pharma 1 to file UAE regulatory submission in Q3 2024; UAE contraceptive market projected $185.1M by 2030.","Pharma 1 pays cost-to-manufacture plus fee; must maintain at least 4 months of inventory at all times.","Evofem closed $500K private placement with Aditxt via 500 shares of Series F-1 Preferred Stock.","Merger with Aditxt targeting September 30, 2024 closing; amended merger agreement dated July 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-028818","json":"https://secwatch.observer/filing/0001493152-24-028818.json","markdown":"https://secwatch.observer/filing/0001493152-24-028818.md","text":"https://secwatch.observer/filing/0001493152-24-028818.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224028818/0001493152-24-028818-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224028818/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:06:30.776508+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}